Stocks and Investing
Stocks and Investing
Tue, August 13, 2024
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
David Nierengarten Initiated (artv) at Buy and Held Target at $18 on, Aug 13th, 2024
David Nierengarten of Wedbush, Initiated "Artiva Biotherapeutics, Inc." (ARTV) at Buy and Held Target at $18 on, Aug 13th, 2024.
David, nor any peers, have made any analyst calls on ARTV in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources